ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals develops and commercializes small molecule drugs for thetreatment of central nervous system disorders.
Type
B2b
Founded
1993
Raised
$40M
Follow us
Alexa global traffic share
Latest funding
$15,000,000
Venture capital - 2011
$25,000,000
Venture capital (Series F) - 2003
Team Size
200+
Employees
Pulse 2.0

ACADIA Pharmaceuticals Stock Price: $28 Target (Down From $50) By Morgan Stanley

Pulse 2.0

ACADIA Pharmaceuticals Stock Price Fell Over 19% Pre-Market: Why It Happened

$52,500,000
Xconomy

Acadia Pharma Acquires CerSci, Potential Pain Meds in $52.5M Buyout

the home of AI info

ACADIA Pharmaceuticals and Vanderbilt University Announce Exclusive License Agreement and …